走西口
Kareena Kapoor Khan Shares Moments From Qatar Grand Prix With Global Icons_我的网站

A | Bollywood actress Kareena Kapoor Khan spent an exciting day at the Qatar Grand Prix 2025, and on Monday she gave fans a closer look by sharing photos and videos from the event on Instagram. Posting a carousel of images, she wrote, “Qatar F1- 2025.”
In the pictures, Kareena is seen enjoying the thrilling Formula 1 atmosphere. Dressed in a stylish look, a crisp white shirt paired with white trousers and a slate-blue blazer, she posed against a scenic background at the racetrack. She was also seen standing near the pit lane, watching the crew work on the cars and getting a glimpse inside the paddock area where the real action happens.
A playful polaroid-style photo included in the post read, “Not music but the sound of (fire emoji),” capturing her excitement as she listened to the roar of the engines. Another picture showed her event wristband, with the caption, “Keeping the band for Tim,” referring to her son Taimur. She also posted a dramatic image of a race car speeding on the track, writing, “What a race!”
More pictures showed Kareena interacting with major international celebrities including chef Gordon Ramsay, former football star David Beckham, and comedian and TV host Steve Harvey. The unexpected combination of personalities instantly went viral, leaving fans amazed.
See her post here:
View this post on Instagram
A post shared by Kareena Kapoor Khan (@kareenakapoorkhan)
Social media users filled the comments section with enthusiastic reactions. One person wrote, “Never thought I’d see Steve Harvey, Gordon Ramsay, David Beckham and Kareena Kapoor in the same frame. This feels like a fever dream.” Another commented, “Kareena and Beckham, OMG!” while others praised her fashion, calling her a “minimalist chic queen” and writing that she looks “as if she’s still in her 20s.”
For those following the race, Max Verstappen won the 2025 Qatar Grand Prix, continuing his remarkable run.
Meanwhile, on the work front, Kareena is currently shooting for Daayra, directed by Meghna Gulzar and co-starring Prithviraj Sukumaran. The film is described as a crime drama exploring themes of justice and punishment. The release date will be announced soon.Also Read: Why Was Manish Malhotra Angry at Farah Khan During Fevicol Se’s Filming?。

Medicine File photo: VCG
China has granted marketing approval of its first drug for the prevention of acute mountain sickness, filling the long-standing gap in the domestic market where no such medications had been available, Science and Technology Daily reported on Tuesday.
The National Medical Products Administration (NMPA) has approved the marketing of acetazolamide sustained-release capsules, the report said. As the first specialized drug in China indicated for preventing of acute mountain sickness, its approval marks the end of the country's lack of dedicated preventive treatment for altitude illness.
By inhibiting the activity of carbonic anhydrase, acetazolamide promotes the renal excretion of bicarbonate, corrects respiratory alkalosis caused by hypoxia at high altitudes, thereby regulating acid-base balance, optimizing respiratory status, elevating blood oxygen levels, and reducing the risk of onset at the source.
In contrast to health products that only provide auxiliary regulatory effects, this medication has been validated through stringent clinical trials and stands as a specialized drug approved by the NMPA with a clear indication for prevention, said the report.
Led by principal investigator is Luobu Gesang, a deputy dean of the People's Hospital of Xizang Autonomous Region, the clinical trial was designed by his team and has yielded critical evidence to inform prevention strategies for altitude sickness that are specifically adapted to Chinese and Asian populations.
"Previously, although acetazolamide had already been used internationally for the prevention of acute mountain sickness, China had long lacked an NMPA-approved acetazolamide formulation supported by rigorous clinical trials. Furthermore, the existing international formulations were short-acting tablets requiring multiple daily doses, and no drugs with the relevant indication were available on the domestic market for an extended period," said Luobu Gesang.
The sustained-release capsule approved this time not only fills this critical gap but also optimizes the dosage form, providing more reliable and convenient medication protection for the physical health and life safety of people entering high-altitude areas, he added.
Clinical trials showed that, compared with the placebo group, the incidence of acute mountain sickness in the medication group was significantly reduced, with the incidence of moderate-to-severe acute mountain sickness decreasing by 14.6 percent, according to the report.
Related research has been published in the international flagship journal of high-altitude medicine, High Altitude Medicine & Biology.
Global Times
。
Current article:http://niujingkongkengjuezan.buzz/news/20260826_137.html
Published on:14:59:50